Founder Alicia Liu Continues to Build a Performance-Oriented Adult Music Community in New York. New York, NY, United States, June 18, 2026 — Music Pathway Choir presented a musical-theater-themed ...

The complement system has an important role in physiological bone healing, as studied mainly in animal models and local bone tissues. However, the role of the complement system in human fractures, ...

Some discoveries change the way we view the human body. In 2021, researchers described what they saw when they had examined skin-biopsy samples that included tattoos: The ink particles had traveled ...

Performances in N.Y.C. Advertisement Supported by These shows demystify a genre unfairly perceived as archaic and stuffy with expert analysis, musical selections and pure fun. By Emma Dibdin Classical ...

Novo Nordisk is paying $240 million for global rights to a Phase 3-ready drug from Omeros that could rival immune disorder medications currently available from companies such as AstraZeneca, Novartis, ...

Lots of people are excited about the idea of using plants to help us draw down some of the excess carbon dioxide we’ve been pumping into the atmosphere. It would be nice to think that we could ...

Animals depend on their sense of smell to locate food, identify mates and evade danger. In mammals, olfactory perception typically relies on G protein–coupled receptor (GPCR) pathways. Insects, by ...

Health tech company Doximity bought Pathway Medical to bulk up its healthcare artificial intelligence capabilities as it looks to offer more free AI tools to doctors. The transaction closed July 29 ...

Doximity has acquired the AI startup Pathway Medical for $63 million. Pathway has one of the largest structured datasets in medicine, Doximity said. The integration is underway, and the companies are ...

Among people with sickle cell disease—an inherited blood disorder—acute chest syndrome (ACS) is the leading cause of death. The condition is the result of red blood cells becoming stiff, sticky, and ...

ARO-C3 treatment led to deep and sustained reductions in alternative pathway complement activity and proteinuria. ARO-C3, an investigational RNA interference-based therapy targeting hepatic expression ...